Aims TheSurgical Treatment for IschemicHeart Failure (STICH) trial demonstratednooverall benefitwhensurgical ventricularreconstruction(SVR)wasaddedtocoronaryarterybypassgrafting(CABG) inpatientswith ischaemic cardiomyopathy.Thepresent analysiswas todeterminewhether, basedonbaseline left ventricular (LV) function parameters, anysubgroupscouldbeidentifiedthatbenefitedfromSVR. Methods andresults Amongthe1000patientsenrolled,CoreLabmeasuresofbaselineLVfunctionwithadequatequalitywereobtained in710patientsusingechocardiography, in352usingcardiovascularmagneticresonance,andin344usingradionuclide imaging.TherelationshipbetweenLVend-systolicvolumeindex(ESVI),end-diastolicvolumeindex,ejectionfraction (EF), regionalwallmotionabnormalities,andoutcomewerefirstassessedonlybyechocardiographicmeasures,and thenby13algorithmsusingadifferenthierarchyof imagingmodalitiesandtheirquality.ThemedianESVIandEFwere 78.0(range:22.8–283.8)mL/m2and28.0%,respectively.Hazardratioscomparingtherandomizedarmsbysubgroups ofLVESVIandLVEFmeasuredbyechocardiographyfoundthatpatientswithsmallerventricles(LVESVI,60mL/m2) andbetterLVEF(≥33%)mayhavebenefittedbySVR,whilethosewithlargerventricles(LVESVI.90mL/m2)and lowerLVEF(≤25%)didworsewithSVR.Algorithmsusingall threeimagingmodalities foundaweakerrelationship betweenLVglobal functionandtheeffectsofSVR.Theextentofregionalwallmotionabnormalitydidnot influence theeffectsofSVR. Conclusions Subgroup analyses of the STICH trial suggest that patients with less dilated LV and better LVEF may benefit fromSVR, while those with larger LV and poorer LVEF may do worse.
Jk, O., Ej, V., L, M., Gm, P., Ro, B., G, L., et al. (2013). Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. EUROPEAN HEART JOURNAL, 34(1), 39-47 [10.1093/eurheartj/ehs021].
Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy.
L ChiarielloInvestigation
;P NardiInvestigation
;
2013-01-01
Abstract
Aims TheSurgical Treatment for IschemicHeart Failure (STICH) trial demonstratednooverall benefitwhensurgical ventricularreconstruction(SVR)wasaddedtocoronaryarterybypassgrafting(CABG) inpatientswith ischaemic cardiomyopathy.Thepresent analysiswas todeterminewhether, basedonbaseline left ventricular (LV) function parameters, anysubgroupscouldbeidentifiedthatbenefitedfromSVR. Methods andresults Amongthe1000patientsenrolled,CoreLabmeasuresofbaselineLVfunctionwithadequatequalitywereobtained in710patientsusingechocardiography, in352usingcardiovascularmagneticresonance,andin344usingradionuclide imaging.TherelationshipbetweenLVend-systolicvolumeindex(ESVI),end-diastolicvolumeindex,ejectionfraction (EF), regionalwallmotionabnormalities,andoutcomewerefirstassessedonlybyechocardiographicmeasures,and thenby13algorithmsusingadifferenthierarchyof imagingmodalitiesandtheirquality.ThemedianESVIandEFwere 78.0(range:22.8–283.8)mL/m2and28.0%,respectively.Hazardratioscomparingtherandomizedarmsbysubgroups ofLVESVIandLVEFmeasuredbyechocardiographyfoundthatpatientswithsmallerventricles(LVESVI,60mL/m2) andbetterLVEF(≥33%)mayhavebenefittedbySVR,whilethosewithlargerventricles(LVESVI.90mL/m2)and lowerLVEF(≤25%)didworsewithSVR.Algorithmsusingall threeimagingmodalities foundaweakerrelationship betweenLVglobal functionandtheeffectsofSVR.Theextentofregionalwallmotionabnormalitydidnot influence theeffectsofSVR. Conclusions Subgroup analyses of the STICH trial suggest that patients with less dilated LV and better LVEF may benefit fromSVR, while those with larger LV and poorer LVEF may do worse.| File | Dimensione | Formato | |
|---|---|---|---|
|
ehs021.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
420.84 kB
Formato
Adobe PDF
|
420.84 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


